BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Diagnosis
14 results:

  • 1. Diagnostic Accuracy of Ultrasound in the diagnosis of uterine Leiomyomas and Sarcomas.
    Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
    J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
    Ma J; Zhang JK; Yang D; Ma XX
    Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
    Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
    Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
    Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
    BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up.
    Horsboel TA; Kjaer SK; Johansen C; Suppli NP; Ammitzbøll G; Frøding LP; Lajer H; Dalton SO
    Gynecol Oncol; 2019 Jun; 153(3):625-632. PubMed ID: 30975472
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer.
    Kim B; Park Y; Kim B; Ahn HJ; Lee KA; Chung JE; Han SW
    J Clin Lab Anal; 2019 Jan; 33(1):e22624. PubMed ID: 30009497
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
    Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
    Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.
    Paes EF; de Assis AM; Teixeira CS; Aoki FH; Teixeira JC
    PLoS One; 2015; 10(6):e0130226. PubMed ID: 26087285
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
    Fu ZC; Wang FM; Cai JM
    Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.
    Diaz A; Moore SP; Martin JH; Green AC; Garvey G; Valery PC
    Int J Gynecol Cancer; 2015 Mar; 25(3):542-7. PubMed ID: 25700033
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
    Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
    Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.
    Giorgi Rossi P; Baiocchi D; Ciatto S;
    Acta Cytol; 2010; 54(3):265-71. PubMed ID: 20518409
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III.
    Lu CH; Liu FS; Kuo CJ; Chang CC; Ho ES
    Obstet Gynecol; 2006 Apr; 107(4):830-5. PubMed ID: 16582119
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.